These potential KIR2.1 positive modulators of IK1 (AgoKirs (Van Der Schoor et al. 2020)) are interesting candidates and starting points in generating pharmacotherapy to relieve or resolve symptoms of ATS (Table 1). Here, KCNJ2 is linked to Andersen-Tawil syndrome.